15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $607M | -$225.7B | 33.9% | -19.3% | -$191M | $344M | $364M |
| 2024 | $713M | -$53.2B | 30.6% | -21.3% | -$208M | $437M | $427M |
| 2023 | $863M | -$188.9B | 36.8% | -18.2% | -$44M | $50600 | $96M |
| 2022 | $1.0B | -$328.4B | 28.7% | -22.5% | -$120M | $256M | $153M |
| 2021 | $1.8B | -$30.1B | 0.0% | 1.1% | $6M | $205M | $135M |
| 2020 | $1.4B | $31M | 0.0% | 4.0% | $6M | $251M | $72M |
| 2019 | $902M | -$315M | 0.0% | -30.4% | -$185M | $270M | $85M |
| 2018 | $990M | -$153M | 0.0% | -17.3% | -$137M | $11M | $96M |
| 2017 | $966M | -$305M | 0.0% | -28.6% | -$139M | $13M | $91M |
| 2016 | $1.1B | -$48M | 49.5% | -8.6% | $13M | $13M | $169M |
| 2015 | $305M | -$52M | 36.7% | -39.5% | $153M | $14M | $194M |
| 2014 | — | -$172M | — | — | -$95M | $16M | $97M |
| 2013 | — | -$114M | — | — | -$60M | $16M | $186M |
| 2012 | — | -$29M | — | — | -$27M | $5M | $27M |
| 2011 | — | -$1M | — | — | -$20M | — | $72M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $124M | -$55M | 36.8% | -41.1% | -$21M | $346M | $332M |
| Dec '25 | $148M | -$31M | 43.1% | -25.8% | -$29M | $344M | $364M |
| Sep '25 | $152M | $22M | 32.9% | 31.7% | -$38M | $344M | $412M |
| Jun '25 | $157M | -$148M | 31.5% | -38.3% | -$87M | $343M | $267M |
| Mar '25 | $150M | -$68M | 28.4% | -44.8% | -$38M | $439M | $429M |
| Dec '24 | $184M | $14M | 46.1% | -18.0% | -$50M | $437M | $427M |
| Sep '24 | $174M | $25M | 23.1% | -38.7% | -$85M | $441M | $400M |
| Jun '24 | $182M | -$10M | 28.4% | -33.9% | -$34M | $202M | $41M |
| Mar '24 | $174M | -$82M | 24.2% | -41.2% | -$40M | $350M | $76M |
| Dec '23 | $182M | -$66M | 0.0% | -38.0% | -$41M | $50600 | $96M |
| Sep '23 | $179M | -$84M | 0.0% | -36.1% | $29M | $251M | $139M |
| Jun '23 | $265M | -$20M | 0.0% | 2.6% | -$6M | $250M | $108M |
| Mar '23 | $238M | -$18M | 0.0% | -12.9% | -$26M | $245M | $111M |
| Dec '22 | $185M | -$85M | 0.0% | -29.8% | -$38M | $256M | $153M |
| Sep '22 | $180M | -$86M | 0.0% | -48.9% | -$40M | $245M | $181M |
| Jun '22 | $310M | -$102M | 0.0% | -3.5% | -$17M | $232M | $210M |
| Mar '22 | $329M | -$55M | 0.0% | -22.0% | -$25M | $230M | $102M |
| Dec '21 | $401M | -$74M | 0.0% | -15.7% | -$12M | $205M | $135M |
| Sep '21 | $386M | $29M | 0.0% | 9.8% | $26M | $203M | $149M |
| Jun '21 | $442M | -$16M | 0.0% | 1.3% | -$24M | $206M | $66M |
How the market has priced OPK against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, OPKO HEALTH, INC.'s revenue has declined 15.8% per year. These are computed facts, not advice.
As of FY2025, OPKO HEALTH, INC. reported $344M of total debt against $364M of cash.
In FY2025, gross margin was 33.9%, operating margin -19.3%, and net margin -37187.0%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.